FC25: Clear Skin, Clarity in Care: Emerging IL-23 Data Highlights for Psoriasis: An Online Activity

Section cover
Released on
December 8, 2025
Duration
43 minutes
Earn up to
0.75 AMA PRA Category 1 Credit


Join our experts, Drs. Bruce Strober, E. James Song, and James Q. Del Rosso, for this symposium delivered during the 2025 Fall Clinical Dermatology Conference®. This session is intended to improve clinicians’ ability to evaluate severity of psoriatic disease severity and select optimal therapy for patients with psoriasis based on the lastest clinical evidence, with a focus on recent data highlights for IL-23 inhibitors.

What we do know is that IL-23 inhibition works consistently across all four special sites. Scalp, I do think takes a little bit longer too, not quite as long as palmoplantar disease. All of that being said, it seems to work consistently well across the domains.” – E. James Song, MD

FC25: Clear Skin, Clarity in Care: Emerging IL-23 Data Highlights for Psoriasis: An Online Activity

This activity is supported by an educational grant from AbbVie.